Aspira Women's Health Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Aspira Women's Health Stock Forecast and Price Target
If the average 2024 price target of $3.30 recently set by prominent experts for Aspira Women's Health is met, there would be a potential upside of approximately 0.61% from the last closing price in April, 2024. The high estimate is $3.30, and the low is $3.30. Even if you are not interested in AWH stock, you should still be aware of its competitors.
0.61% Upside
Aspira Women's Health Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Aspira Women's Health's Price has seen an increase, rising from $0.00 to $0.00. This represents a growth of 100.00%. Analysts predict that Aspira Women's Health's Fair Value will increase in the upcoming year, reaching $3.53. This would represent an increase of 100.00%. Over the next seven years, experts predict that Aspira Women's Health's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$571.73 | Buy/Sell | $591.94 | 7.57% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$230.48 | Buy/Sell | $284.47 | 21.49% |
| WAT Stock Forecast | Waters | Hold |
15
|
$308.35 | Buy/Sell | $323.50 | 7.02% |
| 6951 Stock Forecast | JEOL | Outperform |
18
|
¥6.68k | Buy/Sell | ¥0.00 | 3.31% |
| ARYC Stock Forecast | Arrayit | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
Aspira Women's Health Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Aspira Women's Health's Revenue has seen an increase, rising from $4.65M to $8.18M. This represents a growth of 75.91%. Analysts predict that Aspira Women's Health's Revenue will increase in the upcoming year, reaching $17.65M. This would represent an increase of 115.77%. Over the next seven years, experts predict that Aspira Women's Health's Revenue will grow at a rate of 247.44%.
.jpg)
Aspira Women's Health EBITDA Forecast for 2023 - 2025 - 2030
Aspira Women's Health's EBITDA has grown in the last two years, jumping from $-17.72M to $-32.50M – an increase of 83.41%. According to the 0 analysts polled, in the next year, Aspira Women's Health's EBITDA will fall by 15.47%, reaching $-27.47M. By 2030, professionals believe that Aspira Women's Health's EBITDA will have decreased by 14.06%, falling to $-27.93M.
Aspira Women's Health EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Aspira Women's Health's EBIT has increased by 82.26%, going from $-17.98M to $-32.77M. For the next year, 4 analysts project Aspira Women's Health's EBIT to drop by 46.32%, reaching $-17.59M. The Aspira Women's Health forecast is for EBIT to reach $-4.25B or grow by 12875.44%.
Aspira Women's Health EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Aspira Women's Health's EPS has seen an increase, rising from $-2.44 to $0.00. This represents a growth of 100.00%. Analysts predict that Aspira Women's Health's EPS will increase in the upcoming year, reaching $-1.32. This would represent an increase of 100.00%. Over the next seven years, experts predict that Aspira Women's Health's EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)